149 related articles for article (PubMed ID: 36711612)
1. Active Gαi/o mutants accelerate breast tumor metastasis via the c-Src pathway.
Lyu C; Bhimani AK; Draus WT; Weigel R; Chen S
bioRxiv; 2023 Jan; ():. PubMed ID: 36711612
[TBL] [Abstract][Full Text] [Related]
2. Active Gα
Lyu C; Bhimani AK; Draus WT; Weigel R; Chen S
Mol Cell Biol; 2023; 43(12):650-663. PubMed ID: 38099640
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.
Bjorge JD; Pang AS; Funnell M; Chen KY; Diaz R; Magliocco AM; Fujita DJ
PLoS One; 2011 Apr; 6(4):e19309. PubMed ID: 21541295
[TBL] [Abstract][Full Text] [Related]
4. A truncated phosphorylated p130Cas substrate domain is sufficient to drive breast cancer growth and metastasis formation in vivo.
Kumbrink J; de la Cueva A; Soni S; Sailer N; Kirsch KH
Tumour Biol; 2016 Aug; 37(8):10665-73. PubMed ID: 26867768
[TBL] [Abstract][Full Text] [Related]
5. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
6. A novel role for ezrin in breast cancer angio/lymphangiogenesis.
Ghaffari A; Hoskin V; Szeto A; Hum M; Liaghati N; Nakatsu K; LeBrun D; Madarnas Y; Sengupta S; Elliott BE
Breast Cancer Res; 2014 Sep; 16(5):438. PubMed ID: 25231728
[TBL] [Abstract][Full Text] [Related]
7. Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways.
Chen PH; Peng CY; Pai HC; Teng CM; Chen CC; Yang CR
J Nutr Biochem; 2011 Aug; 22(8):732-40. PubMed ID: 21062671
[TBL] [Abstract][Full Text] [Related]
8. Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation.
Wang S; Yuan Y; Liao L; Kuang SQ; Tien JC; O'Malley BW; Xu J
Proc Natl Acad Sci U S A; 2009 Jan; 106(1):151-6. PubMed ID: 19109434
[TBL] [Abstract][Full Text] [Related]
9. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration.
Qin L; Chen X; Wu Y; Feng Z; He T; Wang L; Liao L; Xu J
Cancer Res; 2011 Mar; 71(5):1742-51. PubMed ID: 21343398
[TBL] [Abstract][Full Text] [Related]
10. Targeting Gi/o protein-coupled receptor signaling blocks HER2-induced breast cancer development and enhances HER2-targeted therapy.
Lyu C; Ye Y; Lensing MM; Wagner KU; Weigel RJ; Chen S
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34343132
[TBL] [Abstract][Full Text] [Related]
11. The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice.
Fereshteh MP; Tilli MT; Kim SE; Xu J; O'Malley BW; Wellstein A; Furth PA; Riegel AT
Cancer Res; 2008 May; 68(10):3697-706. PubMed ID: 18483252
[TBL] [Abstract][Full Text] [Related]
12. Mediation of adenylyl cyclase sensitization by PTX-insensitive GalphaoA, Galphai1, Galphai2 or Galphai3.
Clark MJ; Traynor JR
J Neurochem; 2006 Dec; 99(6):1494-504. PubMed ID: 17230639
[TBL] [Abstract][Full Text] [Related]
13. Systemic Deficiency of PTEN Accelerates Breast Cancer Growth and Metastasis.
Chen J; Sun J; Wang Q; Du Y; Cheng J; Yi J; Xie B; Jin S; Chen G; Wang L; Wang X; Wei H
Front Oncol; 2022; 12():825484. PubMed ID: 35372075
[TBL] [Abstract][Full Text] [Related]
14. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
15. Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression.
Zhao Y; Kumbrink J; Lin BT; Bouton AH; Yang S; Toselli PA; Kirsch KH
Carcinogenesis; 2013 Dec; 34(12):2880-90. PubMed ID: 23825155
[TBL] [Abstract][Full Text] [Related]
16. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T
Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838
[TBL] [Abstract][Full Text] [Related]
17. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.
Muthuswamy SK; Siegel PM; Dankort DL; Webster MA; Muller WJ
Mol Cell Biol; 1994 Jan; 14(1):735-43. PubMed ID: 7903421
[TBL] [Abstract][Full Text] [Related]
18. A critical role of Gbetagamma in tumorigenesis and metastasis of breast cancer.
Tang X; Sun Z; Runne C; Madsen J; Domann F; Henry M; Lin F; Chen S
J Biol Chem; 2011 Apr; 286(15):13244-54. PubMed ID: 21349837
[TBL] [Abstract][Full Text] [Related]
19. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD
Breast Cancer Res; 2005; 7(5):R708-18. PubMed ID: 16168116
[TBL] [Abstract][Full Text] [Related]
20. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
